Trop-2 Is a Determinant of Breast Cancer Survival

By F. Ambrogi, M. Fornili, P. Boracchi, M. Trerotola, Valeria Relli, P. Simeone, R. La Sorda, R. Lattanzio, P. Querzoli, M. Pedriali and 3 more. 2014

Subfields: Cancer Research, Oncology

Citations in the corpus

• TROP2 expression in head and neck squamous cell carcinoma: association with the tumor immune microenvironment and clinical outcome (2026, unknown): “In NSCLC, urothelial carcinoma and breast cancer, TROP2 overexpression has been associated with poor prognosis, altered immune in fi ltration patterns, including increased macrophage recruitment and immune evasion mechanisms (41 – 44).”